Evidence type: Human RCT | Observational | Animal | In vitro | Regulatory Mechanism of Action As a copper chelator, GHK-Cu modulates over 4,000 human genes, upregulating those involved in tissue remodeling (e.g., collagen I, III) and downregulating pro-inflammatory pathways like NF-B
Open 12 (4), e5747
CLA works by inhibiting lipoprotein lipase (LPL)
When used in sunscreen, ubiquinone is shown to increase ingredient stability, increase SPF factor, and add to infrared protection
This publication does not independently substantiate, verify, or endorse those promotional phrases as performance guarantees
We also initiated a fixed dose combination study of zibotentan with Farxiga which has the potential to significantly improve outcomes for patients with kidney disease not well controlled on current standard of care. AstraZeneca stays active Outside of its GLP-1 license deal and earnings release, the British pharma giant also published data from a Phase 3 trial showing that Imfinzi (durvalumab) in combination with transarterial chemoembolisation (TACE) and bevacizumab met its primary endpoint of progression-free survival versus TACE alone in patients with hepatocellular carcinoma eligible for embolization, a type of liver cancer
